- Home
- SFST vs ZYXI Comparison
SFST vs ZYXI Comparison
Compare SFST & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- ZYXI
- Stock Information
- Founded
- SFST 1999
- ZYXI 1996
- Country
- SFST United States
- ZYXI United States
- Employees
- SFST N/A
- ZYXI N/A
- Industry
- SFST Major Banks
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SFST Finance
- ZYXI Health Care
- Exchange
- SFST Nasdaq
- ZYXI Nasdaq
- Market Cap
- SFST 285.9M
- ZYXI 72.3M
- IPO Year
- SFST 1999
- ZYXI N/A
- Fundamental
- Price
- SFST $39.07
- ZYXI $2.22
- Analyst Decision
- SFST Buy
- ZYXI Buy
- Analyst Count
- SFST 1
- ZYXI 3
- Target Price
- SFST $43.00
- ZYXI $6.00
- AVG Volume (30 Days)
- SFST 17.8K
- ZYXI 258.2K
- Earning Date
- SFST 07-21-2025
- ZYXI 07-24-2025
- Dividend Yield
- SFST N/A
- ZYXI N/A
- EPS Growth
- SFST 37.29
- ZYXI N/A
- EPS
- SFST 2.25
- ZYXI N/A
- Revenue
- SFST $97,501,000.00
- ZYXI $172,401,000.00
- Revenue This Year
- SFST $4.07
- ZYXI N/A
- Revenue Next Year
- SFST $8.99
- ZYXI $19.55
- P/E Ratio
- SFST $17.51
- ZYXI N/A
- Revenue Growth
- SFST 11.95
- ZYXI N/A
- 52 Week Low
- SFST $28.74
- ZYXI $1.66
- 52 Week High
- SFST $45.91
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- SFST 58.48
- ZYXI 42.75
- Support Level
- SFST $39.35
- ZYXI $2.31
- Resistance Level
- SFST $40.00
- ZYXI $2.72
- Average True Range (ATR)
- SFST 0.86
- ZYXI 0.18
- MACD
- SFST 0.13
- ZYXI -0.03
- Stochastic Oscillator
- SFST 78.44
- ZYXI 6.25
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.